Ectopic Cushing’s Syndrome as the Initial Presentation of Pulmonary Carcinoid Tumor Managed by Etomidate: A Case Report

  • Masoud Mohebbi Metabolic Syndrome Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Shohreh Vojouhi Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Seyed Alireza Javadinia ORCID Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Faeze Keihanian Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran AND Department of Cardiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. AND Ghaem Hospitals, Mashhad University of Medical Sciences, Mashhad, Iran.AND Pharmaceutical Research Center, Booali Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mohammad Ali Yaghoubi Mail Metabolic Syndrome Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ali Motamedzadeh Torghabeh Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Keywords:
Ectopic cushing, Carcinoid tumor, Etomidate

Abstract

Ectopic increase of adrenocorticotropic hormone (ACTH) or ectopic Cushing syndrome is a rare initial presentation of small cell carcinoma and carcinoid tumor of the lung. Here, we reported a 36-year-old male with atypical symptoms of Cushing syndrome managed by Etomidate that had a central pulmonary nodule, and pathologic evaluation of pulmonary lobectomy revealed the diagnosis of well-differentiated, low-grade typical carcinoids of lung.

References

Newell-Price J, Trainer P, Besser M, Grossman A. The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States. Endocrine Reviews. 1998;19(5):647-72.

Vaduganathan M, Nagarur A, Kerr DA, Lauter KB, Padmanabhan A, Raghavan S, et al. Metastatic pancreatic neuroendocrine tumor with ectopic adrenocorticotropic hormone production. Proceedings (Baylor University Medical Center). 2015;28(1):46.

Meisinger QC, Klein JS, Butnor KJ, Gentchos G, Leavitt BJ. CT features of peripheral pulmonary carcinoid tumors. American Journal of Roentgenology. 2011;197(5):1073-80.

Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, et al. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Annals of oncology. 2015;26(8):1604-20.

Bhansali A, Walia R, Rana S, Dutta P, Radotra B, Khandelwal N, et al. Ectopic Cushing's syndrome: experience from a tertiary care centre. Indian Journal of Medical Research. 2009;129(1):33.

El Hayek MS, Choucair M, Arabi A. Cushing Syndrome due to Ectopic ACTH Secretion Presenting With Lower Limb Edema and Pulmonary Nocardia Infection: Case Report and Review of the Literature. Journal of Endocrinology and Metabolism. 2016;6(5):158-61.

Loriaux DL. Diagnosis and Differential Diagnosis of Cushing’s Syndrome. New England Journal of Medicine. 2017;376(15):1451-9.

Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM. Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clinical endocrinology. 1986;24(6):699-713.

Shepherd FA, Laskey J, Evans WK, Goss PE, Johansen E, Khamsi F. Cushing's syndrome associated with ectopic corticotropin production and small-cell lung cancer. Journal of Clinical Oncology. 1992;10(1):21-7.

Mendonca B, Madureira G, Bloise W, Albergaria A, Halpern A, Liberman B, et al. Cushing syndrome due to ectopic ACTH secretion. Revista paulista de medicina. 1989;107(1):29-36.

Pass HI, Doppman JL, Nieman L, Stovroff M, Vetto J, Norton JA, et al. Management of the ectopic ACTH syndrome due to thoracic carcinoids. The Annals of thoracic surgery. 1990;50(1):52-7.

Reza‐Albarrán AA, Andino Ríos GG, Gómez Herrera LG. Etomidate in the control of severe Cushing's syndrome by neuroendocrine carcinoma. Clinical Case Reports. 2018;6(5):851-4.

Johnson TN, Canada TW. Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor. The Annals of pharmacotherapy. 2007;41(2):350-3.

Drake W, Perry L, Hinds C, Lowe D, Reznek R, Besser G. Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing’s syndrome and peritonitis. The Journal of Clinical Endocrinology & Metabolism. 1998;83(10):3542-4.

Tong CV, Hussein Z. Ectopic ACTH Syndrome–Experience with Etomidate. Journal of the ASEAN Federation of Endocrine Societies. 2017;32(1):54.

Published
2020-01-26
How to Cite
1.
Mohebbi M, Vojouhi S, Javadinia SA, Keihanian F, Yaghoubi MA, Motamedzadeh Torghabeh A. Ectopic Cushing’s Syndrome as the Initial Presentation of Pulmonary Carcinoid Tumor Managed by Etomidate: A Case Report. Acta Med Iran. 57(7):464-467.
Section
Case Report(s)